AbbVie Inc.'s Q1 earnings highlight an 8.4% revenue boost, driven by Skyrizi & Rinvoq. Click for ABBV's market expansion, ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

AbbVie has had a dramatic year, juggling a Humira hangover, political landmines, and a costly failed drug trial. Despite a ...

AbbVie is a popular stock with dividend investors for its high starting yield and continuous dividend increases. AbbVie is a ...

Abbott Elementary Season 4 Episode 22: "Please Touch Museum " – Abbott Elementary goes on a schoolwide field trip to the Please Touch Museum, which has some of the older kids skeptical. ABBOTT ...

AbbVie stock outperformed S&P 500 with a +16% to 9.41% return since November 2023, despite Humira revenue declining 38% to $8.99 billion. Immunology drugs Skyrizi and Rinvoq grew over 50% year ...

Some of the other well-known biologics are powerful, relatively new anti-inflammatory drugs like Humira, which can help patients with everything from severe arthritis to ulcerative colitis.

With equity markets in shambles due to President Donald Trump's trade policies, now might be as good a time as any to invest in excellent dividend stocks. For one, dividend-paying companies tend to be ...

Humira's sales peaked at $21.2 billion ... When counting the time it spent under Abbott Laboratories, AbbVie has increased its payouts for 53 consecutive years. It's not like the drugmaker ...

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of rivalry that includes blockbuster drugs Keytruda, Humira and Eliquis. Obesity is ...

Texas Republican Governor Greg Abbott is facing sharp criticism for delaying a special election to fill the seat of a Democratic U.S. Representative in a solid blue district who died in March. With ...